In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA takes first step in possible reversal of ban on some peptides The Washington Post Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA moves toward easing restrictions on certain peptides BioPharma Dive